CALT Calliditas Therapeutics

USD 40.00 0.00 ( 0.00)%
Icon

Calliditas Therapeutics (CALT) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

Hold

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 40.00

0.00 (0.00)%

USD 1.10B

N/A

USD 40.20(+0.50%)

USD 22.00 (-45.00%)

Icon

CALT

Calliditas Therapeutics (USD)
COMMON STOCK | NSD
USD 40.00
0.00 ( 0.00)%

Calliditas Therapeutics (CALT) Stock Forecast

Show ratings and price targets of :
USD 40.20
(+0.50%)

Based on the Calliditas Therapeutics stock forecast from 5 analysts, the average analyst target price for Calliditas Therapeutics is USD 40.20 over the next 12 months. Calliditas Therapeutics’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Calliditas Therapeutics is Bearish, which is based on 2 positive signals and 6 negative signals. At the last closing, Calliditas Therapeutics’s stock price was USD 40.00. Calliditas Therapeutics’s stock price has changed by +0.00% over the past week, +0.00% over the past month and +131.21% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...